| Application no. and date | 16814513.4 (espacenet) (Federated) (European Patent Register), 20160624 | | Patent/reg. no. and date | DK/EP 3315131, 20220914 | | Publication date | 20180502 | | Priority no. and date | JP 2015127788, 20150625 | | EP pub. no. and date |
EP 3315131 20180502 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27, Kandanishiki-cho
Chiyoda-ku, Tokyo 101-8444, JP | | Applicant ref. no. | PU010111DKQ | | Inventor | FUJIOKA, Akio, c/o Taiho Pharmaceutical Co., Ltd.
3 Okubo
Tsukuba-shi
Ibaraki 300-2611, JP | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/47 (2006.01) , A61P 11/00 (2006.01) , C07D 215/50 (2006.01) | | Title | TERAPEUTISK MIDDEL MOD FIBROSE | | Int. application no. | JP2016068902 | | Int. publication no. | WO2016208744 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
